Your browser doesn't support javascript.
Louisiana Medicaid access for treatment and care for hepatitis C virus (LA-MATCH) project: A cross-sectional study protocol.
Afaneh, Hasheemah; Straif-Bourgeois, Susanne; Oral, Evrim; Wennerstrom, Ashley; Sugarman, Olivia; Robinson, William T; Whittington, Angel; Trapido, Edward.
  • Afaneh H; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Straif-Bourgeois S; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Oral E; Department of Biostatistics, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Wennerstrom A; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Sugarman O; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Robinson WT; Department of Behavioral and Community Health Sciences and Center for Healthcare Value & Equity, New Orleans School of Public Health, LSU Health Sciences Center-New Orleans, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
  • Whittington A; University of Louisiana at Monroe, Medicaid, Monroe, Lousiana, United States of America.
  • Trapido E; Department of Epidemiology, New Orleans School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America.
PLoS One ; 16(10): e0257437, 2021.
Article in English | MEDLINE | ID: covidwho-1456086
ABSTRACT

INTRODUCTION:

This article presents the Louisiana Hepatitis C Elimination Program's evaluation protocol underway at the Louisiana State University Health Sciences Center-New Orleans. With the availability of direct-acting antiviral (DAA) agents, the elimination of Hepatitis C (HCV) has become a possibility. The HCV Elimination Program was initiated by the Louisiana Department of Health (LDH) Office of Public Health (OPH), LDH Bureau of Health Services Financing (Medicaid), and the Louisiana Department of Public Safety and Corrections (DPSC) to provide HCV treatment through an innovative pricing arrangement with Asegua Therapeutics, whereby a fixed cost is set for a supply of treatment over five years. MATERIALS AND

METHODS:

A cross-sectional study design will be used. Data will be gathered from two sources 1) an online survey administered via REDCap to a sample of Medicaid members who are receiving HCV treatment, and 2) a de-identified data set that includes both Medicaid claims data and OPH surveillance data procured via a Data Use Agreement between LSUHSC-NO and Louisiana Medicaid.

DISCUSSION:

The evaluation will contribute to an understanding of the scope and reach of this innovative treatment model, and as a result, an understanding of areas for improvement. Further, this evaluation may provide insight for other states considering similar contracting mechanisms and programs.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Hepatitis C Subject: Antiviral Agents / Hepatitis C Type of study: Clinical Practice Guide / Prevalence study / Risk factors Language: English Journal: PLoS One Clinical aspect: Therapy Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Antiviral Agents / Hepatitis C Subject: Antiviral Agents / Hepatitis C Type of study: Clinical Practice Guide / Prevalence study / Risk factors Language: English Journal: PLoS One Clinical aspect: Therapy Year: 2021
...